Literature DB >> 16897343

No evidence for parental imprinting of mouse 22q11 gene orthologs.

Thomas M Maynard1, Daniel W Meechan, Clifford C Heindel, Amanda Z Peters, Robert M Hamer, Jeffrey A Lieberman, Anthony-Samuel LaMantia.   

Abstract

Non-Mendelian factors may influence central nervous system (CNS) phenotypes in patients with 22q11 Deletion Syndrome (22q11DS, also known as DiGeorge or Velocardiofacial Syndrome), and similar mechanisms may operate in mice carrying a deletion of one or more 22q11 gene orthologs. Accordingly, we examined the influence of parent of origin on expression of 25 murine 22q11 orthologs in the developing and mature CNS using single nucleotide polymorphism (SNP)-based analysis in interspecific crosses and quantification of mRNA in a murine model of 22q11DS. We found no evidence for absolute genomic imprinting or silencing. All 25 genes are biallelically expressed in the developing and adult brains. Furthermore, if more subtle forms of allelic biasing are present, they are very small in magnitude and most likely beyond the resolution of currently available quantitative approaches. Given the high degree of similarity of human 22q11 and the orthologous region of mmChr16, genomic imprinting most likely cannot explain apparent parent-of-origin effects in 22q11DS.

Entities:  

Mesh:

Year:  2006        PMID: 16897343      PMCID: PMC2663429          DOI: 10.1007/s00335-006-0011-0

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  32 in total

1.  Extensive tissue-specific variation of allelic methylation in the Igf2 gene during mouse fetal development: relation to expression and imprinting.

Authors:  M Weber; L Milligan; A Delalbre; E Antoine; C Brunel; G Cathala; T Forné
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

2.  Analysis of candidate imprinted genes linked to Dlk1-Gtl2 using a congenic mouse line.

Authors:  Aleksey Yevtodiyenko; Michael S Carr; Nafisa Patel; Jennifer V Schmidt
Journal:  Mamm Genome       Date:  2002-11       Impact factor: 2.957

3.  RanBP1, a velocardiofacial/DiGeorge syndrome candidate gene, is expressed at sites of mesenchymal/epithelial induction.

Authors:  Thomas M Maynard; Gloria T Haskell; Naina Bhasin; James M Lee; Andrew A Gassman; Jeffrey A Lieberman; Anthony-Samuel LaMantia
Journal:  Mech Dev       Date:  2002-02       Impact factor: 1.882

4.  TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.

Authors:  S Merscher; B Funke; J A Epstein; J Heyer; A Puech; M M Lu; R J Xavier; M B Demay; R G Russell; S Factor; K Tokooya; B S Jore; M Lopez; R K Pandita; M Lia; D Carrion; H Xu; H Schorle; J B Kobler; P Scambler; A Wynshaw-Boris; A I Skoultchi; B E Morrow; R Kucherlapati
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

5.  Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice.

Authors:  E A Lindsay; F Vitelli; H Su; M Morishima; T Huynh; T Pramparo; V Jurecic; G Ogunrinu; H F Sutherland; P J Scambler; A Bradley; A Baldini
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  A quantitative MRI study of posterior fossa development in velocardiofacial syndrome.

Authors:  S Eliez; J E Schmitt; C D White; V G Wellis; A L Reiss
Journal:  Biol Psychiatry       Date:  2001-03-15       Impact factor: 13.382

7.  Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome.

Authors:  T van Amelsvoort; E Daly; D Robertson; J Suckling; V Ng; H Critchley; M J Owen; J Henry; K C Murphy; D G Murphy
Journal:  Br J Psychiatry       Date:  2001-05       Impact factor: 9.319

Review 8.  22q11 DS: genomic mechanisms and gene function in DiGeorge/velocardiofacial syndrome.

Authors:  Thomas M Maynard; Gloria T Haskell; Jeffrey A Lieberman; Anthony-Samuel LaMantia
Journal:  Int J Dev Neurosci       Date:  2002 Jun-Aug       Impact factor: 2.457

9.  Language skills in children with velocardiofacial syndrome (deletion 22q11.2).

Authors:  Bronwyn Glaser; Donna L Mumme; Christine Blasey; Michael A Morris; Sophie P Dahoun; Stylianos E Antonarakis; Allan L Reiss; Stephan Eliez
Journal:  J Pediatr       Date:  2002-06       Impact factor: 4.406

Review 10.  Evolutionarily conserved low copy repeats (LCRs) in 22q11 mediate deletions, duplications, translocations, and genomic instability: an update and literature review.

Authors:  T H Shaikh; H Kurahashi; B S Emanuel
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  6 in total

Review 1.  Bridging the gene-behavior divide through neuroimaging deletion syndromes: Velocardiofacial (22q11.2 Deletion) and Williams (7q11.23 Deletion) syndromes.

Authors:  Daniel Paul Eisenberg; Mbemba Jabbi; Karen Faith Berman
Journal:  Neuroimage       Date:  2010-03-03       Impact factor: 6.556

Review 2.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

Review 3.  Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.

Authors:  D W Meechan; T M Maynard; E S Tucker; A-S LaMantia
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

4.  Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Christian R Marshall; Anath C Lionel; Eva W C Chow; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

Review 5.  Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.

Authors:  Melis Inan; Timothy J Petros; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2012-11-29       Impact factor: 5.996

6.  Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome.

Authors:  R Das Chakraborty; D Chakraborty; A J Bernal; K Schoch; T D Howard; E H Ip; S R Hooper; M S Keshavan; R L Jirtle; V Shashi
Journal:  Transl Psychiatry       Date:  2012-04-24       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.